Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — New Study Concludes That Crime Reduction Effects of Cannabis Legalization Are Underestimated

For years, drug-reform activists in America argued that the country’s prohibitionist policies were counterproductive; instead of curbing drug abuse and crippling the criminal enterprises behind the drug trade, prohibition has imprisoned countless people of color for minor drug charges, shackling them with criminal records for the rest of their lives, and enriched the drug cartels that supply the black market with drugs.

Decades after former President Richard Nixon declared the war on drugs, the movement has been declared a failure by most pundits. Drug-reform advocates argued that rather than prohibit the sale of cannabis, launching a legal, regulated market would do what the war on drugs sought to do much more effectively.

Now a new study has found that not only does cannabis have a positive effect on crime reduction but that the effect of legalizing the controversial plant on crime numbers has actually been underestimated. Ever since American states began legalizing cannabis for medical and recreational use, several studies have attempted to look at the relationship between crime numbers and cannabis laws.

However, researchers have been severely limited in their research methodology, the study found, as they rely on FBI data collected from local police departments across the country. Since reporting this data to the FBI is entirely voluntary, the result is that the data on crime and cannabis underplays the extent to which medical cannabis laws have affected violent and property crime.

The study involved researchers from the U.S. Department of Agriculture’s (“USDA”) Economic Research Service and Appalachian State University in Boone, North Carolina. The researchers say that the country’s drug policy presumes that prohibition has a negative effect on crime rates, but unfortunately, insufficient data has made it impossible to test this assumption in medical marijuana states.

To get around the knowledge gap, the researchers developed a novel imputation procedure that allowed them to reduce the measurement error bias and estimate the true extent of medical marijuana laws on violent and property crimes, they write in the final paper titled “Smoke and Fear: The Effects of Marijuana Prohibition on Crime.”

The group’s final estimations revealed that medical marijuana laws would be followed by significant reductions in violent and property crime rates, especially in Mexican border states. This is likey because people are more likely to buy cannabis from legal vendors who have to ensure their products are safe, tested and meet certain standards, especially if they are using it medicinally.

Aside from reducing crime, medical marijuana is having an even bigger impact on the health and well-being of its users, and these positive effects could grow as more people adopt tools such as the RYAH Smart Inhaler manufactured by RYAH Group Inc. (CSE: RYAH) for the purpose of precisely measuring the dose of marijuana flower that medical marijuana users smoke.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Cannabis Legalization Caused Significant Decline in Illegal Cannabis Seizure Samples

Research led by a top cannabis investigator for the federal government revealed that state-level cannabis legalization has left the DEA with few samples of seized illicit marijuana to analyse. This finding supports the claim made by legalization advocates that consumer demand for unregulated marijuana from illicit channels will decrease as more legal markets are established.

The study, which was published in the “Biological Psychiatry” journal, was authored by Mahmoud ElSohly. ElSohly is in charge of the country’s sole federally authorized marijuana growing facility at the University of Mississippi. The study states that the number of samples received over the last five or so years has declined significantly because of the legalization of cannabis for either recreational or medical purposes in various states in the United States.

The decreasing number of seizures reported in the study provides the latest indication of the shrinkage of the unregulated market while the marijuana legalization movement spreads as more states legalize the plant for medical or recreational use.

Recent data released by the FBI also shows that cannabis arrests are also declining across the country, with numbers from last year showing significant decreases. An analysis from the U.S. Sentencing Commission that was released earlier this year found that federal cannabis trafficking cases also dropped last year as more states moved to legalize. A separate report released by Supreme Court Chief Justice John Roberts found that while cases involving cannabis declined by roughly a quarter, federal prosecutions of drug-related crimes increased overall in 2019.

Another study released in 2018 by the Cato Institute discovered that state-level cannabis legalization had considerably undercut cannabis smuggling. A recent study published in “Biological Psychiatry” also found that even as the number of DEA illicit marijuana samples gradually declines as the legalization movement spreads, the more limited supply shows that THC potency grew over time.

The study discovered that the average THC potency in seized cannabis increased from about 9.7% in 2009 to 14.8% in 2018, then it decreased slightly in 2019 to 13.8%. In addition, the average CBD concentration in seized cannabis dropped to 0.14% in 2017 from 0.4% in 2009. In 2019, CBD concentration then increased to 0.6%.

Legislators, researchers and advocates have argued that research that relies on the government’s marijuana is compromised, given that it usually contains considerably lower cannabinoid levels in comparison with the products sold in state-legal dispensaries.

Legalization has also made it possible for massive growth to be registered in different sectors of the cannabis industry, and the continuing success of companies such as Simply Sonoma Inc. provides concrete proof of that growth.

NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma Inc. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Must-Know Benefits of Diapers Made from Hemp

Until a couple of years ago, the cultivation and sale of hemp were outlawed in the United States. Thanks to the 2018 Farm Bill, however, farmers can now grow hemp once their states or tribes opt into the hemp program and draft rules for the hemp market.

Hemp and marijuana are from the same family of plants with the caveat that hemp does not intoxicate users because it has limited amounts of THC, the chemical compound responsible for marijuana’s psychoactive effects. Despite this, hemp has enjoyed continued demand since commercial cultivation thanks to its wide variety of applications. Hemp has an almost unlimited range of uses, including rope, textiles, shoes, food, paper, and bioplastics, but I bet you’ve never heard of hemp diapers.

Hemp is known to make a durable fiber that can be spun into diapers that are vastly superior to what you would find on the market. Reusable diapers are extremely uncommon these days with more than 90% of American families using disposable diapers. With more than 4 million babies born in the U.S. every year, and families using up to 28 billion disposable diapers each year, the environmental impact of disposable diapers is catastrophic, especially since the diapers take roughly 100 years to fully break down; they also leach harmful chemicals into the ground. On the other hand, hemp diapers are wholly organic, can be reused, and are biodegradable, unlike the disposable varieties.

If Americans were to turn to reusable hemp diapers, the amount of waste material generated by the average American family, especially ones with newborn babies, would be significantly reduced. And since hemp diapers are extremely durable, they are stronger than traditional diapers and can last much longer. Once such a diaper is used, it can be easily cleaned without the need for expensive detergents, softener or bleach.

As such, hemp diapers are a completely organic, carbon-neutral alternative to traditional diapers. Diapers made from hemp also have antibacterial properties that make them resistant to a wide range of pathogenic bacteria. This makes them ideal for babies because they prevent the growth or spread of harmful bacteria from the waste material within the diapers.

Additionally, hemp diapers are more breathable compared to traditional disposable diapers, making them great for both the health of a baby’s skin as well as their comfort. Nonbreathable options often lead to diaper dermatitis and do not allow odors to escape, meaning a child may remain in a soiled diaper for some time before parents notice that a change is needed. The diapers are also water absorbent and are mold resistant, and have antimicrobial properties.

Hemp diapers are far superior to traditional options in many ways: they are more comfortable, resist the growth of bacteria and mold, and are easy on the environment. Only time will tell whether they will outpace disposable diapers that have now become the norm in America.

As hemp diapers make their way into the mainstream, hemp fabrics manufactured by companies such as Flora Growth Corp. (NASDAQ: FLGC) are widely available and offer a great way to appreciate the superiority of hemp clothing.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — New CBD Law in California Draws Industry-Wide Attention

Last week, the governor of California signed into law a reform that opens the state’s economy globally to manufacturers of hemp-derived CBD products. The bill the governor signed, dubbed AB45, creates a framework for the manufacture and sale of hemp-derived products in the state.

The measure will allow hemp-derived CBD products to be sold to the state’s adult-use or medical cannabis retailers, with forecasts showing that those stores will hit sales of between $4.8 billion and $5.7 billion this year. Canopy Growth Corp.’s (TSX: WEED) (NASDAQ: CGC) head of lobbying, David Culver, states that officials had been working on this measure for more than two years.

Canopy Growth is involved in the manufacture of CBD products derived from hemp, which include a line of CBD gummies and Biosteel sports drinks. However, the company hasn’t been selling those products in California because the state’s cannabis policy didn’t allow the sale of over-the-counter CBD products.

In an interview, Culver stated that the measure would open up the state’s market and offer regulatory certainty for retailers in California to assure them that their products for sale won’t be confiscated or seized. Back in 2018, a ban on hemp-derived CBD in drinks and dietary supplements and food led to product seizures and occasional raids.

CV Sciences senior vice president of scientific and regulatory affairs Doug MacKay stated that before the 2018 ban, the company had been operating successfully in California and had built a lot of relationships. CV Sciences is involved in the manufacture and sale of hemp-derived CBD products. It sells its products in CVS drugstores and other countrywide retailers. After the ban, the company, which is based in California, had to stop distributing its products in brick-and-mortar shelves in the state.

MacKay applauds cannabis and hemp negotiators for not giving up until a compromise for the sale of CBD products was reached. In his statement, he noted that the measure marked a clear pathway to the market and afforded retailers a clear way to work with other CBD companies that are willing to have the right labeling and follow the laws.

However, not everyone is happy with the measure, as the ban on smokable hemp is still intact, which leaves hemp farmers at a disadvantage. National Industrial Hemp Council spokesperson Larry Farnsworth stated that the measure would affect hemp farmers in the state who grow smokable hemp flower. Some hemp producers in the state have even threatened to file a lawsuit over the new measure.

Those grumbles notwithstanding, the passing of the CBD law in California is likely to broaden the market for leading manufacturers of CBD products.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Unveils New Cannabis Wellness Brand

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, and its Flora Lab division is launching Munzhi, a new cannabis wellness brand. The mass market brand will initially include 12 products, all certified by INVIMA, the Colombian branch of government that is equivalent to the United Stated Food and Drug Administration. The products will be distributed by five Colombian distributors, including Herson, Mintlab, Unidrogas, Roma and Axa, and will be available in an estimated 800 distribution points. Flora Lab is FLGC’s manufacturing and R&D division; Flora Lab is focused on development of pharmaceuticals, cosmetics and nutraceuticals. According to the announcement, the wellness market in Colombia has reached a $2.3 billion value, and Munzhi will be operating in this space. Initial Munzhi products will include facial serum, shampoo, conditioner, shower gel, body ointment, moisturizing lotion and more .“Through market studies, consumers have indicated they want the wellness benefits of cannabis but at an affordable price,” said Flora Growth president and CEO Luis Merchan in the press release. “Munzhi helps fill that need as well as an important gap in our product portfolio. The inaugural collection for Munzhi includes 12 products across four categories: wellness, hair, body and face. The collection combines the benefits of cannabidiol as an active ingredient, with other plant-based ingredients such as lavender oil and chamomile coconut amongst others.”

To view the full press release, visit https://cnw.fm/IFVw1

About Flora Growth Corp.

Flora Growth is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — A Primer on Marijuana Beverages and Reasons Why People Drink Them

Marijuana-infused beverages are the latest cannabis products to see a surge in popularity. With a growing number of states passing cannabis legislation and lawmakers considering federal decriminalization, cannabis is more accessible to the public than ever before. Within a few years of legalization, the sector has become extremely lucrative, generating billions of dollars in revenue partly due to marijuana’s purported medical benefits and the fact that the plant can be infused into a wide variety of products. For the past couple of years, cannabis concentrates and edibles have reigned supreme, with CBD gummies being one of the most searched-for food products in 2018.

Now, another segment of the cannabis market has muscled its way into the mainstream. Although companies have been toying with the idea of cannabis drinks for a couple of years, the technology needed to infuse cannabinoids into water hadn’t been developed. Cannabinoids, the chemical compounds responsible for marijuana’s effects, aren’t water soluble and will not easily mix with water.

Efforts to try and mix the two initially resulted in products that were far inferior to the alcoholic beverages on the market. Lynden Hendersen of Outbound Brewing described an early cannabis drink as tasting like “milk that had been sitting in a refrigerator for two or three months,” saying that it was chunky with an unpleasant consistency and texture. But thanks to nano emulsification technology, cannabis companies can now develop smooth, consistent drinks.

These drinks do not contain high levels of THC, the cannabinoid that makes consumers feel high, with whatever impact they have usually kicking in anywhere from five to 30 minutes after consumption. This makes the products perfect for a drinking session at the bar because users will feel buzzed relatively quickly but not so much that they are very high.

Choosing these drinks is essentially microdosing, which means taking a smaller dose for a limited effect of the drug, and this limited dosing still delivers marijuana’s health benefits. Cannabis drinks are also a safer option compared to alcoholic drinks. Generally, cannabis is much safer than alcohol, with fewer adverse effects on the body and no fatal dose, unlike alcohol. By eliminating the smoking aspect, individuals who drink cannabis in lieu of alcohol have a significantly reduced risk of health issues, including liver cirrhosis.

Furthermore, most cannabis drinks have zero calories and carbs, while plenty of alcoholic drinks have a ton of empty calories. This makes cannabis drinks the better option for people who would like to have a fun night out without messing with their diet. They are also perfect for individuals who would like to try cannabis but cannot or do not want to smoke, vape or eat edibles; recovering alcoholics who are weaning themselves off of alcohol; and people who require lower doses of cannabis.

Regardless of the reason why users would choose a cannabis drink, companies such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) offer a wide variety of infused drinks to choose from.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — An Update on Drug Reform Measures to Be Voted on in November

Voters in different states across the country will have the chance to vote on various psychedelics and cannabis measures at the state and local level in November. Legislators and advocates have been working hard to get local psychedelics reform and marijuana decriminalization measures on their ballots before this cycle ends. Below is a list of some of the states whose measures will appear on next month’s ballot.

Philadelphia, Pennsylvania

The city council of Philadelphia recently placed a measure on the local ballot that urged the state to enact legalization of marijuana. The initiative states that citizens of Philadelphia call upon the governor and the Pennsylvania General Assembly to approve legislation that will decriminalize, tax and regulate the sale and use of marijuana for nonmedical purposes to individuals aged 21 and above.

While the measure will not make any immediate changes to the law if it is passed by voters, it will put pressure on state lawmakers to act on the legalization bills being filed.

Municipalities of Ohio

Voters in more than a dozen municipalities in the state of Ohio will also get a chance to approve ballot measures on cannabis decriminalization in November. These measures will be brought before voters in Yorkville, Tiltonsville, Rayland, Powhatan Point, New Straitsville, New Lexington, Murray City, Mount Pleasant, Morristown, McArthur, Martins Ferry, Laurelville, Dillonvale and Brookside.

Currently, 22 jurisdictions in the state have already adopted statutes decriminalizing marijuana possession.

Now activists have succeeded in getting a marijuana proposal that will decrease the local punishment for low-level cannabis possession to the lowest penalty permitted by state law on next month’s ballot. The lowest penalty translates to a fine of $0 and 0 days in jail.

Detroit

In the state of Michigan, activists in Detroit have succeeded in placing an initiative on the ballot that would decriminalize psychedelics such as ayahuasca and psilocybin.

Recently, a pair of senators in the state introduced a measure that would legalize the delivery, growing and possession of various fungi and plant-derived psychedelics, including mescaline and psilocybin. The measure’s approval would prompt legislators to seriously consider broader reform.

Colorado

Colorado was one of the first states to legalize the use of cannabis for recreational purposes. Now legislators are hoping that voters will approve the LEAP initiative, which would increase marijuana taxes to fund programs that have been designed to decrease the education gaps for studies from low-income families.

The program, known as the Learning Enrichment and Academic Progress program, will also give middle- and low-income families a small stipend to have children take part in summer learning, tutoring and after-school activities.

As more jurisdictions enact marijuana market laws, companies such as American Cannabis Partners that operate on a multistate model will have plenty of options to choose from as they expand their footprint across the country.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Study Reveals Effectiveness of Proprietary Drug-Development Tech

Lexaria Bioscience (NASDAQ: LEXX), developers of the revolutionary DehydraTECH(TM) drug-delivery technology, has released study results focused on THC-A21-1, a THC oral format. According to the announcement, the study showed that Lexaria’s DehydraTECH THC solution delivers THC levels to blood plasma an estimated three times faster than standard MCT-based THC. Based on study results, it took only 15 minutes using oral ingestion of the substance to reach THC levels comparable to those reached in 45 minutes using “coconut-oil” formulations. As the THC left the system at the six-hour mark, levels were comparable and demonstrated the fast-on, fast-off performance. The DehydraTECH results are timely because the House Judiciary Committee last week passed the MORE Act, which signifies a general movement toward federal legalization of the drug. While the LEXX study was focused on the potential of advancing DehydraTECH THC as a medicinal solution, the results can be applied to a larger market. “THC consumers today include . . . medicinal and pharmaceutical users,” said Lexaria BioScience CEO Chris Bunka in the press release. “Our objective is to provide them rapid onset and high bioavailability without harmful delivery mechanisms like smoking.”

To view the full press release, visit https://cnw.fm/xBK6z

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption of cannabinoids and nicotine by 5 to 10 times, and, in some instances with cannabinoids by as much as 27 times, compared to standard industry formulations, as well as reduce time of onset from one to two hours to minutes, and mask unwanted tastes. The delivery systems are also being evaluated for orally administered, anti-viral drugs, nonsteroidal, anti-inflammatory drugs (NSAIDs) and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 21 patents granted and more than 50 patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Granted Approval to Evaluate Sensory Factors in Product-Development Trials

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) has received an amendment to a cannabis research license it had previously been granted by Health Canada. The amendment allows the company to include sensory evaluations of cannabis beverages in an upcoming product development trial. According to the announcement, the company will be able to conduct onsite human assessments of the taste, smell, feel and visual appeal of products the company is developing, a move that BevCanna says will provide significant advantages for its white-label clients as well as in-house brands because the new-product trial capabilities are unique in the Canadian cannabis beverage market. The company points out that the ability to assess these key factors allows the company to test, evaluate and refine product offerings according to consumer preferences, which can increase the commercial success of new products. “Being able to test the taste, smell, feel and visual appeal of our products gives us a significant advantage in being able to develop the innovative, appealing beverages that BevCanna is known for in the cannabis beverage market,” said BevCanna president Melise Panetta in the press release. “This advancement further cements our position as the premier specialty cannabis beverage manufacturer in Canada.”

To view the full press release, visit https://cnw.fm/C3j2N

About BevCanna Enterprises Inc.

BevCanna Enterprises is a diversified health and wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the BevCanna team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, BevCanna owns a pristine alkaline spring water aquifer and a world-class, 40,000-square-foot, HACCP-certified manufacturing facility, with a bottling capacity of up to 210 million bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with number-one U.S. cannabis beverage company Keef Brands. For more information about the company, please visit www.BevCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://cnw.fm/BVVNF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Many Patients with Breast Cancer Use Marijuana Alongside Meds

Over the past couple of years, cannabis has grown increasingly popular as more states pass legislation to allow either medical marijuana or recreational cannabis. With advocates across the country advocating for state measures and lawmakers discussing federal decriminalization, cannabis has come a long way from the days of prohibition.

As it has slowly shed its unfounded reputation as a destructive drug, cannabis has interestingly moved into the health and wellness space thanks to a diverse range of purported health benefits. By May 2018, more than 3.5 million registered medical marijuana patients existed across the country, with countless more using recreational marijuana to try and alleviate their health issues.

However, despite cannabis’ popularity as a medical alternative, most scientists caution that the hype has far outpaced the science. While marijuana definitely has medical potential, using it as an alternative to pharmaceuticals, especially without the knowledge and permission of a doctor, can be quite dangerous. According to recently published research, such a situation is unfolding in America among individuals suffering from breast cancer. The study, which was published in “Cancer,” an American Cancer Society peer-reviewed journal, found that nearly half of American adults suffering from breast cancer use marijuana alongside their treatment to manage side effects and symptoms.

Various types of cancer and their treatments often cause pain, fatigue, insomnia, nausea and other health issues. Although studies have found that cannabis can indeed alleviate issues such as chronic pain, lack of appetite and insomnia, many physicians are not comfortable discussing it as a treatment option due to the limited knowledge on cannabis’ risks and benefits.

To find the rate of cannabis use among breast cancer patients, the researchers conducted an online survey of 612 participants. An estimated 42% of respondents said they had used cannabis to treat symptoms such as pain, insomnia, anxiety, nausea and vomiting with 75% of those who used cannabis reporting that it was extremely or very helpful.

Disturbingly, 49% of the participants who used marijuana believed medical cannabis could treat cancer, a claim that is still unproven by scientists. Almost 80% of the cannabis users had taken cannabis while undergoing other treatments such as surgery, radiation and systemic therapies. Half of those patients had looked for information on medical cannabis with websites and other patients being the most popular sources of information and physicians being the least popular. Most of the respondents were not satisfied with the information they received on medical cannabis. Furthermore, participants used cannabis products of varying quality and purity, mistakenly assuming that the products were safe and tested.

The researchers concluded that health providers ought to initiate informed conversations about medical marijuana with their patients. The fact that cancer patients are using cannabis without their doctors’ knowledge is a “major blind spot” in ability of health-care providers to provide suitable care, the researchers say. Initiating informed conversations will allow doctors to properly manage the symptoms and side effects of cancer and cancer treatment while minimizing potential side effects and treatment interactions.

The findings that plenty of women are using marijuana alongside their prescription medications seems to reaffirm how much the public has come to trust medicinal cannabis products such as those made by companies such Hero Technologies Inc. (OTC: HENC).

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.